Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INOVAOPIOID: Opioid-Sparing vs Opioid-Based Regimen in Cardiac Surgery
NCT03679013Phase 2Completed
- Sponsor
- Inova Health System
- Start
- Apr 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of gabapentin and acetaminophen in postoperative pain (2 arms), sponsored by Inova Health System. Primary endpoints: Number of Patients With Requests for Breakthrough Opioid Pain Medication at 72 hours and Average Pain Score at 72 hours. Started Apr 2019; status: completed.
02
Drugs
gabapentinacetaminophen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03679013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03679013.